Los estudios han demostrado que lograr una prdida de peso sostenida del 10 % o ms proporciona beneficios para la salud clnicamente significativos
In the SUSTAIN 1-7 series of clinical trials which investigated the effectiveness of once weekly semaglutide injections for the treatment of diabetic and obese patients, semaglutide consistently demonstrated significant reductions in HbA1c levels compared to placebo and other usual diabetes medications (metformin, sitagliptin, dulaglutide)
It stimulates collagen and elastin synthesis, promotes wound healing, reduces inflammation, and perhaps most remarkably appears to reset the expression of hundreds of genes associated with aging back toward younger patterns [2]
Understanding the distinction between branded, generic, and compounded GLP-1 options matters for your treatment decision
These can include prescription medications that stimulate bowel movements or address specific underlying causes